Actimed

Actimed Therapeutics Secures Significant New Patent, Extending IP Coverage of its Lead Compound for Use in Key Indication

London, UK - 4 May 2022: Actimed Therapeutics Ltd, a clinical stage company focused on bringing innovation to the treatment of muscle wasting disorders, today announced the grant of a new UK Patent (GB 2593902 B) covering new salts of S-pindolol for use in the treatment or prevention of cachexia with an expiry date in...
The Old Bakehouse, Course Road, Ascot, Berkshire, SL5 7HL